Magnetic resonance imaging of amyloid plaque in the brain

US9320452B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9320452-B2
Application numberUS-63158105-A
CountryUS
Kind codeB2
Filing dateJun 28, 2005
Priority dateJul 6, 2004
Publication dateApr 26, 2016
Grant dateApr 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Amyloid plaque in the brain of a subject is imaged in an MRI system with or without the use of a contrast agent. Contrast is achieved using a spin-echo pulse sequence that is both respiratory gated and cardiac gated to reduce motion artifacts at the very high image resolution required to see plaque. A preparatory pulse sequence is used to insure longitudinal magnetization remains constant for all the acquired views even if the effective TR changes during the scan due to irregular breathing.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for acquiring an in vivo, high resolution magnetic resonance image from a subject, the steps comprising: a) producing a trigger signal when the subject is in a preselected phase of the subject's respiratory cycle; b) performing a pulse sequence to acquire an NMR signal when the trigger signal is produced, the pulse sequence including: b)i) performing a preparatory pulse sequence to create uniform view-to-view longitudinal magnetization in the presence of non-uniform view-to-view trigger times in which the longitudinal magnetization in a region of interest in the subject is set to a preset amount by applying an rf nulling pulse with a substantially 90° flip angle followed by a preset null recovery time (TN); b)ii) producing transverse magnetization in the region of interest by applying an rf excitation pulse after step b)i); b)iii) producing an NMR echo signal at a preselected time (TE) after application of the rf excitation pulse; b)iv) acquiring the NMR echo signal in the presence of a readout magnetic field gradient; c) changing a magnetic field gradient in the pulse sequence and repeating step b) to acquire another NMR signal; and d) repeating step c) until sufficient NMR echo signals are acquired to reconstruct an image. 2. The method as recited in claim 1 in which the region of interest is in the subject's brain. 3. The method as recited in claim 2 in which the region of interest is in a portion of the subject's brain containing amyloid plaque and the NMR echo signal is produced in step b)iii) by producing an rf refocusing pulse. 4. The method as recited in claim 1 in which the rf nulling and rf excitation pulses are adiabatic half-passage RF pulses that flip substantially all of the longitudinal magnetization into the transverse plane. 5. The method as recited in claim 1 in which the pulse sequence performed in step b) further includes: producing a first selective RF refocusing pulse in the presence of a first gradient after step b)ii) to refocus the transverse magnetization in a first slice through the region of interest; and producing a second selective RF refocusing pulse in the presence of a second gradient after step b)ii) to refocus the transverse magnetization in a second slice through the region of interest. 6. The method as recited in claim 5 in which the selective RF refocusing pulses are hyperbolic scant type pulses. 7. A method for acquiring an in vivo, high resolution magnetic resonance image from a subject, the steps comprising: a) producing a first trigger signal when the subject is in a preselected phase of the subject's respiratory cycle; b) performing a preparatory pulse sequence when the first trigger signal is produced by applying an rf nulling pulse followed by a preset null recovery time (TN); c) producing a second trigger signal when the subject is in a preselected phase of the subject's cardiac cycle; d) performing an imaging pulse sequence to acquire an NMR echo signal from a selected region of interest in the subject after the second trigger signal is produced; and e) repeating steps a) through d) until sufficient NMR echo signals are acquired to reconstruct an image. 8. The method as recited in claim 7 in which the rf nulling pulse has a substantially 90° flip angle. 9. The method as recited in claim 7 in which step d) includes: d)i) producing transverse magnetization in the region of interest by applying an rf excitation pulse; b)ii) producing an NMR echo signal at a preselected time (TE) after application of the rf excitation pulse; and d)iii) acquiring the NMR echo signal in the presence of a readout magnetic field gradient. 10. The method as recited in claim 9 in which the region of interest is in a portion of the subject's brain containing amyloid plaque and the NMR echo signal is produced in step d)ii) by producing an rf refocusing pulse. 11. The method as recited in claim 10 in which step d) further includes: producing a first selective RF refocusing pulse in the presence of a first gradient after step d)i) to refocus the transverse magnetization in a first slice through a region of interest; and producing a second selective RF refocusing pulse in the presence of a second gradient after step d)i) to refocus the transverse magnetization in a second slice through the region of interest.

Assignees

Inventors

Classifications

  • Gating or triggering based on a physiological signal other than an MR signal, e.g. ECG gating or motion monitoring using optical systems for monitoring the motion of a fiducial marker · CPC title

  • for synchronizing or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal · CPC title

  • A61B5/055Primary

    involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title

  • Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9320452B2 cover?
Amyloid plaque in the brain of a subject is imaged in an MRI system with or without the use of a contrast agent. Contrast is achieved using a spin-echo pulse sequence that is both respiratory gated and cardiac gated to reduce motion artifacts at the very high image resolution required to see plaque. A preparatory pulse sequence is used to insure longitudinal magnetization remains constant for a…
Who is the assignee on this patent?
Garwood Michael G, Jack Jr Clifford R, Poduslo Joseph F, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61B5/055. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).